The World Health Organization sounds the international alarm over a lethal Bundibugyo virus outbreak…
At least 246 suspected cases and 80 deaths are tearing through the Ituri Province of the Democratic Republic of the Congo…
International spread is officially confirmed. Two patients entered intensive care units in Kampala, Uganda…
Four healthcare workers have already perished, triggering severe anxiety over hospital-borne transmission vectors…
Medical authorities warn that unlike other strains, there are currently zero approved vaccines or therapeutics for Bundibugyo…
The health lines are breaking down in central Africa…
WHO invoked its highest alert under International Health Regulations.
On 5 May 2026, WHO received an alert regarding an unknown illness with high mortality reported in Mongbwalu Health Zone, Ituri Province, including four health workers who died within four days. Following an in-depth investigation by the rapid response team in Mongbwalu and Rwampara health zones (HZ) on 13 May, the outbreak was subsequently confirmed as Bundibugyo virus disease (BVD) due to Bundibugyo virus (BDBV) (Orthoebolavirus bundibugyoense, species) on 15 May.
On 15 May 2026, the Ministry of Public Health, Hygiene and Social Welfare officially declared the 17th Ebola Disease outbreak in the DRC, occurring in Rwampara, Mongwalu and Bunia HZ.
The first currently known suspected case, a health worker, reported onset of symptoms including fever, hemorrhaging, vomiting and intense malaise on 24 April 2026. The case died at a medical centre in Bunia.
As of 15 May, a total of 246 suspected cases and 80 deaths (four deaths among confirmed cases) have been reported from three HZ: Rwampara (six health areas affected), Mongbwalu (three health areas affected), and Bunia . Twenty four suspected cases are currently in isolation facilities across the three HZ. In addition, unusual clusters of community deaths with symptoms compatible with Bundibugyo virus disease (BVD) are being investigated across other HZ in Ituri and North Kivu.
A further case reported on 16 May, an individual returning from Ituri to Kinshasa, has tested NEGATIVE for Bundibugyo virus on confirmatory testing by the Institut National de la Recherche Biomédicale (INRB) of DRC, and is therefore not considered a confirmed case.
Most of the suspected cases are between 20 and 39 years old, with females accounting for over 60%, suggesting significant risks associated with household and caregiver transmission.
Initial testing of 20 samples collected in Rwampara HZ and analysed at the Provincial Public Health Laboratory in Bunia using standard Ebola Xpert were negative for Ebola virus. Samples were sent to INRB for further analysis, of which eight samples analysed were confirmed as Orthoebolavirus by polymerase chain reaction (PCR) on 15 May. Genomic sequencing confirmed the virus species as Bundibugyo virus (BDBV).
As of 15 May, 65 contacts have been listed, with 15 identified as high-risk. However, follow-up remains weak due to insecurity and movement restrictions. Several listed contacts became symptomatic and died before they could be isolated.
On 15 May 2026, the Ministry of Health of Uganda confirmed an outbreak of BVD following the identification of an imported case from the DRC. The case is an elderly man who was admitted to a private hospital on 11 May with severe symptoms and died on 14 May. The post-mortem transfer of the body to DRC was completed the same day. A clinical sample collected when the case was admitted on 11 May was tested at the Central Emergency Surveillance and Response Support Laboratory, Wandegeya, and was confirmed as Bundibugyo virus on 15 May 2026. A second imported case was confirmed on 16 May in Kampala, in an individual returning from DRC with no apparent links to the first case. At the time of reporting, no local transmission has been identified in Uganda.
On 16 May 2026, the Director-General of WHO, after having consulted the States Parties where the event is known to be currently occurring as defined in the provisions of the International Health Regulations (2005) (IHR), determined that the Ebola disease caused by Bundibugyo virus in DRC and Uganda constitutes a PHEIC.
It is currently thought that the event originated in the Mongbwalu HZ, DRC, a high-traffic mining area, with cases subsequently migrating to Rwampara and Bunia to seek medical care. Ituri province borders South Sudan and Uganda (and Bunia HZ is less than 500km from Uganda). A full epidemiological investigation and trace back exercise is ongoing.
Ituri’s role as a commercial and migratory hub and proximity to Uganda and South Sudan increases the risk of regional exportation and cross-border transmission.
Figure 1. Health Zones affected by Bundibugyo virus disease in Democratic Republic of Congo, as of 16 May 2026
17th DRC Outbreak; centered in mining and commercial hubs of Mongbwalu and Rwampara, Ituri.
88 deaths / 300+ suspected cases; including critical medical staff dying within days of exposure.
The epicenter in eastern Congo is a total war zone, making real containment a fantasy. While the official tally sits at 8 laboratory-confirmed cases and 246 suspected ones, local residents are reporting multiple daily burials that never hit the official books. The medical establishment spent years bragging about their new Ebola vaccines, but they forgot to mention those shots are totally useless against this rare Bundibugyo strain.
The real nightmare is how long this thing ran silent before anyone noticed. Four healthcare workers died before the lab in Kinshasa realized their field kits were looking for the wrong virus. By the time they adjusted the tests, the infection had already traveled 1,000 kilometers to the capital and jumped the border into Uganda. They are telling us not to panic and advising against border closures, which is standard script when they want to avoid a economic freeze. But when a hemorrhagic virus with no cure hits major transit hubs, the old playbook is garbage. They are flying blind into a regional hotspot with empty syringes and broken data.
.png?sfvrsn=db9a40db_3)